Pregna Launches CryoPop – a Carbon Dioxide (CO2) Based Innovative Cryotherapy Device to Fight Cervical Cancer
2 min read
Pregna International Ltd. has furthered its status as a leading women's healthcare organisation with the launch of its ground-breaking cryotherapy dev
MUMBAI, India--(BUSINESS WIRE)--ice - CryoPop.

The ingenious device was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device.

WHO's declaration in November 2020 encouraged all nations to work together to accelerate in eliminating the disease with its 3 pronged strategy - 90% HPV vaccination coverage, 70% screening coverage, and 90% access to treatment for cervical pre-cancer and cancer.

"Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and middle-income countries in sub-Saharan Africa, Melanesia, Latin America, the Caribbean, South-Central and South-East Asia. India alone accounts for nearly 23% of these fatalities. The good news is that thanks to advancements in screening and diagnosis, cervical cancer is not only preventable, but also one of the most…
Read full article